BAM

Brave Asset Management Portfolio holdings

AUM $409M
1-Year Est. Return 19.38%
This Quarter Est. Return
1 Year Est. Return
+19.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$409M
AUM Growth
+$42.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
178
New
Increased
Reduced
Closed

Top Buys

1 +$1.71M
2 +$1.41M
3 +$1.21M
4
BAC icon
Bank of America
BAC
+$858K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$679K

Top Sells

1 +$587K
2 +$542K
3 +$350K
4
FCX icon
Freeport-McMoran
FCX
+$306K
5
CMCSA icon
Comcast
CMCSA
+$218K

Sector Composition

1 Technology 14.02%
2 Financials 10.35%
3 Communication Services 9.41%
4 Consumer Discretionary 3.35%
5 Industrials 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
151
Teladoc Health
TDOC
$1.35B
$103K 0.02%
13,275
-1,725
DLTH icon
152
Duluth Holdings
DLTH
$119M
$95.8K 0.02%
24,500
XRX icon
153
Xerox
XRX
$356M
$73.3K 0.02%
+19,500
RIG icon
154
Transocean
RIG
$4.86B
$71.8K 0.02%
23,000
UROY
155
Uranium Royalty Corp
UROY
$497M
$68.8K 0.02%
16,000
DHF
156
BNY Mellon High Yield Strategies Fund
DHF
$185M
$65K 0.02%
25,100
URG
157
Ur-Energy
URG
$493M
$64.4K 0.02%
36,000
RXRX icon
158
Recursion Pharmaceuticals
RXRX
$2.41B
$55.8K 0.01%
11,433
MDCX
159
Medicus Pharma
MDCX
$48.5M
$46.3K 0.01%
+20,000
PROP icon
160
Prairie Operating Co
PROP
$112M
$39.7K 0.01%
20,000
ONCY
161
Oncolytics Biotech
ONCY
$106M
$35K 0.01%
25,000
MIN
162
MFS Intermediate Income Trust
MIN
$303M
$26.8K 0.01%
10,000
KOPN icon
163
Kopin
KOPN
$430M
$24.3K 0.01%
10,000
BLNK icon
164
Blink Charging
BLNK
$150M
$23K 0.01%
14,000
ORGN icon
165
Origin Materials
ORGN
$71.4M
$11.4K ﹤0.01%
22,000
LUCYW icon
166
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$2.36K ﹤0.01%
31,388
ASTLW icon
167
Algoma Steel Group Warrant
ASTLW
$3.94M
$1.53K ﹤0.01%
10,000
RBOT.WS icon
168
Vicarious Surgical Inc Warrants
RBOT.WS
$148K
$500 ﹤0.01%
25,000
BMY icon
169
Bristol-Myers Squibb
BMY
$100B
-4,400
CHPT icon
170
ChargePoint
CHPT
$191M
-1,150
CMCSA icon
171
Comcast
CMCSA
$97.3B
-6,112
DOV icon
172
Dover
DOV
$25.4B
-1,179
EDIT icon
173
Editas Medicine
EDIT
$235M
-25,000
THAR icon
174
Tharimmune
THAR
$91.1M
-10,000
ESGR
175
DELISTED
Enstar Group
ESGR
-1,040